openPR Logo
Press release

Vasculitis Market Opportunities and Forecast by 2024

05-26-2017 03:42 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Ranging from mild to life threatening, short term to life long, Vasculitis is a term for a group of rare diseases that have in common, a condition that destroys blood vessels by inflammation. Affecting both sexes and all ages, vasculitis is caused by leukocyte migration and can affect arteries and veins in the body. Lymphangitis can also be considered as a type of vasculitis. Fever, weight loss, abdominal pain, myocardial infraction, arthralgia and others are the possible symptoms of vasculitis. This disorder can affect the blood vessels such as arteries, capillaries and veins in the body as it results in poor blood flow to tissues throughout the body, such as the lungs, nerves and skin. If the blood vessel is inflamed it blocks or closes the path for blood flow that leads to aneurysm. Shortness of breath, numbness in hand or foot, red spots on the skin, lumps or sores are some of the common symptoms of Vasculitis. Though vasculitis of the kidneys may produce no symptoms at first, but it still remains a serious predicament. Often requiring treatment with immunosuppressive drugs, Vasculitics diseases are inflammatory health problems whose early detection and treatment can prevent permanent damage. Glucocorticoids comprises an integral part of the medication used to treat vasculitis. The dosage and the length of the treatment depends on the severity of the disease and the personal history of the patient. An autoimmune disease where the body comes under attack by its own immune system, some cases of Vasculitis are also caused by reactions to medicines.

Browse through Vasculitis Market report to know what factors will shape the market by 2024: http://www.transparencymarketresearch.com/vasculitis-market.html

Vasculitis is a very rare disease and some of the types of vasculitis diseases are mentioned below:

By large vessel vasculitis
Behçet's Disease
Cogan's Syndrome
Giant Cell Arteritis
Polymyalgia Rheumatica
Takayasu's Arteritis

By medium vessel vasculitis
Buerger's Disease
Central Nervous System Vasculitis
Kawasaki Disease
Polyarteritis Nodosa

By small vessel vasculitis
Churg-Strauss Syndrome
Essential Mixed Cryoglobulinemia
Henoch-Schönlein Purpura
Hypersensitivity Vasculitis
Microscopic Polyangiitis
Wegener's Granulomatosis

Rising incidences of metabolic disorders and circulatory diseases would accentuate the growth of this disease. Center of Disease Control and Prevention (CDC) estimated that in the year 2013 around 8,000,000 people were diagnosed with peripheral arterial disease (PAD) and is expected to grow significantly in near future owing to sedentary and changing lifestyle. This, the above mentioned factors drive the growth of this market globally. However, lack of awareness is one of the restraining factor of this market.

Geographically, North America is the leading region for the global vasculitis market owing to increasing healthcare awareness. In addition, rise in circulatory diseases namely, peripheral vascular diseases also accentuates the growth in this region. The market in Asia-Pacific region is expected to grow at a significant due to rise in disposable income and increasing healthcare awareness.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Market by 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14966

Vasculitis Market Key Players

Some of the key players engaged in developing vasculitis therapeutics market are Novartis AG, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., RNL BIO Co., Ltd., Teijin Pharma Limited, Anthera Pharmaceuticals‚ Inc., Human Genome Sciences, Inc.¸ Troikaa Pharmaceuticals Ltd., and Genentech, Inc. among others.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vasculitis Market Opportunities and Forecast by 2024 here

News-ID: 552667 • Views: 353

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Vasculitis

Vasculitis Market - Competitive Analysis and Forecast 2024
Ranging from mild to life threatening, short term to life long, Vasculitis is a term for a group of rare diseases that have in common, a condition that destroys blood vessels by inflammation. Affecting both sexes and all ages, vasculitis is caused by leukocyte migration and can affect arteries and veins in the body. Lymphangitis can also be considered as a type of vasculitis. Fever, weight loss, abdominal pain, myocardial
Vasculitis Market Segments and Key Trends 2016-2024
Ranging from mild to life threatening, short term to life long, Vasculitis is a term for a group of rare diseases that have in common, a condition that destroys blood vessels by inflammation. Affecting both sexes and all ages, vasculitis is caused by leukocyte migration and can affect arteries and veins in the body. Lymphangitis can also be considered as a type of vasculitis. Fever, weight loss, abdominal pain, myocardial
Global Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculit …
Market Research Hub's clinical trial report, Global Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Clinical Trials Review, H1, 2017 , provides an overview of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Request Free Sample
Vasculitis Treatment Market - Global Industry Analysis 2024
A group of disorder caused by the inflammation of blood vessels is known as vasculitis (plural: vasculitides), also called angiitis. Vasculitis includes inflammation of arteries, veins, and/or capillaries. The disease can affect both males and females equally without any age specifications. Quite a few forms of vasculitis are present, and their scientific characteristics can vary considerably in terms of severity, symptoms, as well as the duration of disease. It
Vasculitis Treatment Market - Global Industry Analysis 2024
A group of disorder caused by the inflammation of blood vessels is known as vasculitis (plural: vasculitides), also called angiitis. Vasculitis includes inflammation of arteries, veins, and/or capillaries. The disease can affect both males and females equally without any age specifications. Quite a few forms of vasculitis are present, and their scientific characteristics can vary considerably in terms of severity, symptoms, as well as the duration of disease. It
Global Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculit …
"The Report Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" GlobalData's clinical trial report, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2016" provides an overview of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) clinical trials scenario. This report provides top line data relating to the clinical